Newsfeeds - Spark Newswire

1 minute read

Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study

Today, 2:03 AM

Valneva SE (NASDAQ:VALN) reported further heterologous booster data from an exploratory, small clinical study for its inactivated COVID-19 vaccine, VLA2001. The…

AZN

1 minute read

Valneva Concludes FDA Regulatory Submission For One-Shot Chikungunya Vaccine

By Vandana Singh

Today, 2:03 AM

Valneva SE (NASDAQ:VALN) completed a rolling regulatory submission step with the FDA for its single-shot chikungunya vaccine candidate, VLA1553, in persons…

VALN

2 minute read

US Stocks Open Lower; Dow Drops Over 100 Points

By Lisa Levin

Today, 2:03 AM

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 100 points on Friday.

ACMR

1 minute read

Valneva Priced 21M Share Global Offering of American Depositary Shares @$9.51/ADS

By Charles Gross

Today, 2:03 AM

Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) announced today the pricing of 21,000,000 ordinary shares in a global offering to specified categories of investors comprised of a public offering of 375,000 American Depositary Shares ("ADSs"), each representing two ordinary shares, in the United States (the "U.S.

PARIS:VLA

4 minute read

Valneva Announces Launch Of Approximately $40 Million In Proposed Global Offering Of American Depositary Shares, Ordinary Shares

By Michael Horton

Today, 2:03 AM

Valneva SE (NASDAQ:VALN, PARIS:VLA) (the "Company"), a specialty vaccine company, today announced its intention to issue and sell, subject to market conditions, approximately $40 million of its

PARIS:VLA